Capital markets, CDFIs, and organizational credit risk

Can Community Development Financial Institutions (CDFIs) get unlimited amounts of low cost, unsecured, short- and long-term funding from the capital markets based on their organizational credit risk? Can they get pricing, flexibility, and procedural parity with for-profit corporations of equivalent credit risk? One of the key objectives of this book is to explain the reasons why the answer to the two questions above remains “no.” The other two key objectives are to show the inner workings of what has been done to date to overcome the obstacles so that we don’t have to retrace the same steps and recommend additional disciplines that position CDFIs to take advantage of the mechanisms of the capital markets once the markets stabilize

British Contributions to Medical Research and Education in Africa after the Second World War

©The Trustee of the Wellcome Trust, London, 2001. First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2001. All volumes are freely available online at: www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/Annotated and edited transcript of a Witness Seminar held on 3 June 1999. Introduction by Dr Maureen Malowany.Annotated and edited transcript of a Witness Seminar held on 3 June 1999. Introduction by Dr Maureen Malowany.Annotated and edited transcript of a Witness Seminar held on 3 June 1999. Introduction by Dr Maureen Malowany.Annotated and edited transcript of a Witness Seminar held on 3 June 1999. Introduction by Dr Maureen Malowany.Differences in health services, research and medical education between British East and West Africa over the period to 1980, including the effects of the transition to independent states, were discussed by witnesses with an extraordinary wealth of diverse talent and experience, directed by the chairman, Professor David Bradley. The increased postwar influence of the Medical Research Council in the tropics was described, aided by a seat on the Colonial Medical Research Committee and its successor body, the MRC-based Tropical Medicine Research Board. Research outcomes of programmes in non-infectious diseases and nutrition, along with the great vector-borne diseases, including sleeping sickness and malaria, and helminth eradication spread through the tropics and also influenced treatment in the UK. The importance of Africa for the postwar development of drug treatments for tropical diseases was underlined. Witnesses include: Dr Murray Baker, Sir Christopher Booth, Dr Christopher Draper, Professor Alan Fleming, Professor Herbert Gilles, Dr Len Goodwin, Professor Ralph Hendrickse, Dr Tom Hopwood, the late Professor Michael Hutt, Professor Sir Ian McGregor, Professor George Nelson, Professor Eldryd Parry, Professor Gerry Shaper, Professor John Waterlow, and Dr Roger Whitehead. Reynolds L A, Tansey E M. (eds) (2001) British contributions to medical research and education in Africa after the second world war, Wellcome Witnesses to Twentieth Century Medicine, vol. 10, London: The Wellcome Trust Centre for the History of Medicine at UCL.The Wellcome Trust Centre for the History of Medicine at UCL is funded by the Wellcome Trust, which is a registered charity, no. 210183

Cholesterol, Atherosclerosis and Coronary Disease in the UK, 1950–2000.

Annotated and edited transcript of a Witness Seminar held on 8 March 2005. Introduction by Dr Nick Myant, Hammersmith Hospital, London.First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2006. ©The Trustee of the Wellcome Trust, London, 2006. All volumes are freely available online at: www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/Annotated and edited transcript of a Witness Seminar held on 8 March 2005. Introduction by Dr Nick Myant, Hammersmith Hospital, London.Annotated and edited transcript of a Witness Seminar held on 8 March 2005. Introduction by Dr Nick Myant, Hammersmith Hospital, London.Annotated and edited transcript of a Witness Seminar held on 8 March 2005. Introduction by Dr Nick Myant, Hammersmith Hospital, London.Annotated and edited transcript of a Witness Seminar held on 8 March 2005. Introduction by Dr Nick Myant, Hammersmith Hospital, London.Annotated and edited transcript of a Witness Seminar held on 8 March 2005. Introduction by Dr Nick Myant, Hammersmith Hospital, London.Annotated and edited transcript of a Witness Seminar held on 8 March 2005. Introduction by Dr Nick Myant, Hammersmith Hospital, London.Cholesterol began to be accepted after the Second World War as a significant cause of atherosclerosis and associated conditions such as coronary heart disease (CHD). This Witness Seminar, chaired by Professor Michael Oliver, included a discussion of the basic research on cholesterol. Early epidemiological studies demonstrated the relationship between excess saturated fat consumption and elevated levels of cholesterol, although cholesterol alone did not explain all population differences. Work on lipoprotein metabolism pointed to hypercholesterolaemia as one of, if not the major, risk factors for CHD, culminating in the development of cholesterol-lowering drugs, particularly the successful statins, available in the UK from the 1980s, and confirmed by randomized controlled trials. The role of diet in heart disease had always been controversial in the UK, and although extreme diets could reduce cholesterol, patient conformity remains difficult. Later, recommended limits on the composition of dietary fat were agreed, assisted by the food industry's introduction of functional foods such as cholesterol-lowering margarine. An introduction by Dr Nick Myant and appendices, on the diet-heart hypothesis by Professor Gerry Shaper and the development of lovastatin by Dr Jonathan Tobert, compliment the transcript. Contributors include Professor David Barker, Professor John Betteridge, Professor Gustav Born, Professor Richard Bruckdorfer, Professor George Davey Smith, Professor Paul Durrington, Professor David Galton, Dr Arthur Hollman, Professor Steve Humphries Professor Gordon Lowe, Professor Vincent Marks, Dr Paul Miller, Professor Jerry Morris, Professor Chris Packard, Professor Stuart Pocock, Professor Kalevi Pyörälä, Professor Thomas Sanders, Professor James Scott, Dr Elspeth Smith, Professor Anne Soutar, Professor Gilbert Thompson, Professor Hugh Tunstall-Pedoe, Professor Neville Woolf and Professor John S Yudkin. Reynolds L A, Tansey E M. (eds) (2006) Cholesterol, atherosclerosis and coronary disease in the UK, 1950–2000, Wellcome Witnesses to Twentieth Century Medicine, vol. 27. London: The Wellcome Trust Centre for the History of Medicine at UCL.The Wellcome Trust Centre for the History of Medicine at UCL is funded by the Wellcome Trust, which is a registered charity, no. 210183

Childhood asthma and beyond

Consists of the edited transcripts of Witness Seminars organized by the History of Twentieth Century Medicine Group and held at the Wellcome Institute for the History of Medicine, London, on 4 April 2000.First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2001. ©The Trustee of the Wellcome Trust, London, 2001. All volumes are freely available online at: www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/Consists of the edited transcripts of Witness Seminars organized by the History of Twentieth Century Medicine Group and held at the Wellcome Institute for the History of Medicine.The Wellcome Trust Centre for the History of Medicine at UCL is funded by the Wellcome Trust, which is a registered charity, no. 210183

The Development of Sports Medicine in Twentieth-century Britain

Annotated and edited transcript of a Witness Seminar held on 29 June 2007. Introduction by Dr John Lloyd Parry, Institute of Sports and Exercise Medicine. First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2009. ©The Trustee of the Wellcome Trust, London, 2009. All volumes are freely available online at: www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/Annotated and edited transcript of a Witness Seminar held on 29 June 2007. Introduction by Dr John Lloyd Parry, Institute of Sports and Exercise Medicine.Annotated and edited transcript of a Witness Seminar held on 29 June 2007. Introduction by Dr John Lloyd Parry, Institute of Sports and Exercise Medicine.Annotated and edited transcript of a Witness Seminar held on 29 June 2007. Introduction by Dr John Lloyd Parry, Institute of Sports and Exercise Medicine.Annotated and edited transcript of a Witness Seminar held on 29 June 2007. Introduction by Dr John Lloyd Parry, Institute of Sports and Exercise Medicine.Sports medicine has grown in importance and visibility in recent years, yet as a discipline it struggled to gain broad recognition within the medical profession from c.1952 until specialty status was granted in 2005. It has also been neglected by historians: we have little beyond the image of a coach with his ‘magic sponge’ as a cure for all injuries, although the late twentieth-century picture is of new specialists developing high-tech interventions for elite athletes. This Witness Seminar arose from the Wellcome Trust-funded project on ‘Sport and Medicine in Britain, 1920–2000’ at the University of Manchester and examined the establishment of a recognizably modern specialty. Chaired by Professor Domhnall MacAuley, topics addressed included the importance of the 1948 London Olympics; the first 4-minute mile; training and altitude physiology; the postwar institutionalization of sports medicine; the relationship between the different main bodies involved in sport and their aims; the changing practice of professionals including physiotherapists, etc.; the relationship of NHS and private sports medicine practitioners and insurance companies; and the key debates within the sports medicine community over the period. Contributors include: Sir Roger Bannister, Dr Malcolm Bottomley, Dr Ian Burney, Professor John Elfed Davies, Professor Charles Galasko, Dr Robin Harland, Dr Vanessa Heggie, Mr Barry Hill, Professor Michael Hobsley, Dr Michael Hutson, Professor Monty Losowsky, Professor Domhnall Macauley (chair), Mrs Rose Macdonald, Professor Donald Macleod, Professor Moira O’Brien, Dr Malcolm Read, Professor Peter Sperryn, Professor Harry Thomason, Dr Dan Tunstall Pedoe and Mrs Sally Williams. Reynolds L A, Tansey E M. (eds) (2009) The development of sports medicine in twentieth century Britain. Wellcome Witnesses to Twentieth Century Medicine, vol. 36. London: The Wellcome Trust Centre for the History of Medicine at UCL. ISBN 978 085484 1219The Wellcome Trust Centre for the History of Medicine at UCL is funded by the Wellcome Trust, which is a registered charity, no. 210183

Early Development of Total Hip Replacement

Annotated and edited transcript of a Witness Seminar held on 14 March 2006. Introduction by Dr Francis Neary and Professor John Pickstone. First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2007. ©The Trustee of the Wellcome Trust, London, 2007. All volumes are freely available online at: www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/Annotated and edited transcript of a Witness Seminar held on 14 March 2006. Introduction by Dr Francis Neary and Professor John Pickstone,Annotated and edited transcript of a Witness Seminar held on 14 March 2006. Introduction by Dr Francis Neary and Professor John Pickstone,Annotated and edited transcript of a Witness Seminar held on 14 March 2006. Introduction by Dr Francis Neary and Professor John Pickstone,Annotated and edited transcript of a Witness Seminar held on 14 March 2006. Introduction by Dr Francis Neary and Professor John Pickstone,Annotated and edited transcript of a Witness Seminar held on 14 March 2006. Introduction by Dr Francis Neary and Professor John Pickstone,Annotated and edited transcript of a Witness Seminar held on 14 March 2006. Introduction by Dr Francis Neary and Professor John Pickstone,Total hip replacement effectively began in the UK in 1938 and has led to widely used, commercially successful, mass-produced devices that relieve pain for an ever increasing period. The Witness Seminar, chaired by Mr Alan Lettin, discussed the remarkable postwar collaboration of British surgeons, engineers and manufacturing firms in the development of efficient alloys, surgical procedures, instruments and the implementation of clean, bacteria-reduced air in enclosed operating theatres, as illustrated by successful prostheses and techniques developed in Norwich (Kenneth McKee), Wrightington (Sir John Charnley), Stanmore (John Scales), Redhill (Peter Ring), and Exeter (Robin Ling and Clive Lee). Early failures - such as loosening from infection, osteolysis, and wear debris - stimulated the search for improved materials and fixation methods, as well as the addition of antibiotics to bone cement to reduce infection. National hip registers that record the survival of different implants were adopted in Europe in the 1970s (2003 in the UK), and they pinpoint the successful devices, as measured by survival and low rates of revision. An introduction to the volume by Dr Francis Neary and Professor John Pickstone, and appendices on materials by Professor Alan Swanson; on international standards by Mr Victor Wheble; and of details of selected prosthesis supplement the transcript. Contributors include: Lady Charnley, the late Mr Harry Craven, Mr Graham Deane, Professor Duncan Dowson, Mr Reg Elson, Dr Alex Faulkner, Professor Michael Freeman, Mrs Phyllis Hampson, Mr Kevin Hardinge, Mr Mike Heywood-Waddington, Mr John Kirkup, Mr Krishna (Ravi) Kunzru, Miss Betty Lee, Mr Alan Lettin (chair), Mr John Older, Mr John Read, Mr Peter Ring, Mr Ian Stephen, Mr Malcolm Swann, Professor Alan Swanson, Sir Rodney Sweetnam, Mr Keith Tucker, Mr Victor Wheble and Professor Michael Wroblewski. Reynolds L A, Tansey E M. (eds) (2007) Early development of total hip replacement, Wellcome Witnesses to Twentieth Century Medicine, vol. 29. London: The Wellcome Trust Centre for the History of Medicine at UCL.The Wellcome Trust Centre for the History of Medicine at UCL is funded by the Wellcome Trust, which is a registered charity, no. 210183

Clinical Pharmacology in the UK, c.1950-2000: Industry and Regulation

Annotated and edited transcript of a Witness Seminar held on 25 September 2007. Introduction by Professor Parveen Kumar, Barts and the London School of Medicine and Dentistry, University of London.First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2008. ©The Trustee of the Wellcome Trust, London, 2008.All volumes are freely available online at: www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/Annotated and edited transcript of a Witness Seminar held on 25 September 2007. Introduction by Professor Parveen Kumar, Barts and the London School of Medicine and Dentistry, University of London.Annotated and edited transcript of a Witness Seminar held on 25 September 2007. Introduction by Professor Parveen Kumar, Barts and the London School of Medicine and Dentistry, University of London.Annotated and edited transcript of a Witness Seminar held on 25 September 2007. Introduction by Professor Parveen Kumar, Barts and the London School of Medicine and Dentistry, University of London.Annotated and edited transcript of a Witness Seminar held on 25 September 2007. Introduction by Professor Parveen Kumar, Barts and the London School of Medicine and Dentistry, University of London.Annotated and edited transcript of a Witness Seminar held on 25 September 2007. Introduction by Professor Parveen Kumar, Barts and the London School of Medicine and Dentistry, University of London.Annotated and edited transcript of a Witness Seminar held on 25 September 2007. Introduction by Professor Parveen Kumar, Barts and the London School of Medicine and Dentistry, University of London.Clinical pharmacology in the UK in the 1950s and 1960s was an exciting profession. Many important new drugs were developed and brought to market and a more systematic knowledge of drug effects in humans was needed, as well as ensuring the safety and efficacy of new and existing drugs, especially following the unexpected problems arising from the use of thalidomide. This Witness Seminar followed an earlier meeting on the history of the general development of clinical pharmacology and focuses on the development of clinical pharmacology in pharmaceutical companies and drug regulation. Professor Rod Flower chaired the meeting of clinical pharmacologists and others who shaped the discipline, which discussed the main centres of influence; the attraction to clinical pharmacologists of working in industry; whether the decline in the number of academic clinical pharmacologists was paralleled in drug companies; what drove drug regulation; and the relationships between companies and regulatory authorities. Participants included Dr Jeffrey Aronson, Professor Nigel Baber, Sir Alasdair Breckenridge, Sir Iain Chalmers, Professor Joe Collier, Professor Donald Davies, Dr Peter Fletcher, Dr Arthur Fowle, Professor Sir Charles George, Professor David Grahame-Smith, Professor John Griffin, Dr Andrew Herxheimer, Professor Ray Hill, Dr Peter Lewis, Dr Tim Mant, Professor Denis McDevitt, Professor Michael Orme, Dr Anthony Peck, Professor Brian Prichard, Professor Sir Michael Rawlins, Professor John Reid, Professor Philip Routledge, Dr Julian Shelley, Dr Robert Smith, Professor Cameron Swift, Professor Tilli Tansey, Dr Duncan Vere, and the late Professor Owen Wade. Reynolds L A, Tansey E M. (eds) (2008) Clinical pharmacology in the UK, c. 1950–2000: Industry and regulation. Wellcome Witnesses to Twentieth Century Medicine, vol. 34. London: The Wellcome Trust Centre for the History of Medicine at UCL.The Wellcome Trust Centre for the History of Medicine at UCL is funded by the Wellcome Trust, which is a registered charity, no. 210183

Global rules, patent power and our food future: controlling the food system in the 21st century

The rules affecting our food future have been rewritten since the early 1990s, often in remote international bodies. This paper briefly outlines the nature of today's food system, discusses some of these rules and focuses on the dynamics of rule making in the World Trade Organisation, in particular around patent, plant variety protection, trademark, copyright and other forms of 'intellectual property' and their impact on our food future. It draws on work with negotiators dealing with the Trade-Related Aspects of Intellectual Property Rights Agreement (TRIPS) in WTO and its role in globalisation.Intellectual property rights regimes, WTO, patents, biotechnology

Clinical Pharmacology in the UK, c.1950-2000: Influences and Institutions

Annotated and edited transcript of a Witness Seminar held on 6 February 2007. Introduction by Dr Mark Walport, The Wellcome Trust.First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2008.©The Trustee of the Wellcome Trust, London, 2008.All volumes are freely available online at: www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/Annotated and edited transcript of a Witness Seminar held on 6 February 2007. Introduction by Dr Mark Walport, The Wellcome Trust.Annotated and edited transcript of a Witness Seminar held on 6 February 2007. Introduction by Dr Mark Walport, The Wellcome Trust.Annotated and edited transcript of a Witness Seminar held on 6 February 2007. Introduction by Dr Mark Walport, The Wellcome Trust.Annotated and edited transcript of a Witness Seminar held on 6 February 2007. Introduction by Dr Mark Walport, The Wellcome Trust.Annotated and edited transcript of a Witness Seminar held on 6 February 2007. Introduction by Dr Mark Walport, The Wellcome Trust.Annotated and edited transcript of a Witness Seminar held on 6 February 2007. Introduction by Dr Mark Walport, The Wellcome Trust.The history of clinical pharmacology in the UK over the last half of the twentieth century is largely untold. Many important new drugs were developed and brought to market in the 1950s and 1960s ensuring the need for more systematic knowledge of drug effects in humans and also providing new career opportunities in teaching, research and practice. The 30th anniversary of the British Journal of Clinical Pharmacology in 2004 and the 75th anniversary of the British Pharmacological Society in 2006 had prompted reflections from practicing clinical pharmacologists. It was timely, therefore, to bring together clinical pharmacologists and others who have shaped the discipline, to promote historical analysis and debate. Chaired by Professor Rod Flower, the meeting considered such questions as: What was/is clinical pharmacology? Which were the main centres of influence? Who and what were the main drivers? Who became clinical pharmacologists and why? What was the significance of specialized societies, meetings and journals? Participants included Dr Stuart Anderson, Dr Jeffrey Aronson, Professor David Barnett, Dr Linda Beeley, Professor Sir James Black, Professor Morris Brown, Professor Mark Caulfield, Sir Iain Chalmers, Professor Donald Davies, Professor Robin Ferner, Dr Arthur Fowle, Professor Sir Charles George, Professor David Gordon, Professor David Grahame-Smith, Dr Andrew Herxheimer, Dr Kenneth Hunter, Professor Trevor Jones, Professor Desmond Laurence, Professor Denis McDevitt, Professor Walter Nimmo, Professor Michael Orme, Dr Anthony Peck, Professor Laurie Prescott, Professor Brian Prichard, Professor John Reid, Professor James Ritter, Professor Philip Routledge, Professor Tilli Tansey, Professor Geoffrey Tucker, Professor Patrick Vallance, Professor Duncan Vere, the late Professor Owen Wade, Professor David Webb and Professor Frank Woods. Reynolds L A, Tansey E M. (eds) (2008) Clinical pharmacology in the UK, c. 1950–2000: Influences and institutions. Wellcome Witnesses to Twentieth Century Medicine, vol. 33. London: The Wellcome Trust Centre for the History of Medicine at UCL.The Wellcome Trust Centre for the History of Medicine at UCL is funded by the Wellcome a registered charity, no. 210183

Maternal Care

This is the edited transcript of a Witness Seminar held at the Wellcome Institute for the History of Medicine, London, on 6 June 2000. First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2001.©The Trustee of the Wellcome Trust, London, 2001. All volumes are freely available online at: www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/Annotated and edited transcript of a Witness Seminar held on 6 June 2000. Introduction by Dr Hilary Marland, University of Warwick.Annotated and edited transcript of a Witness Seminar held on 6 June 2000. Introduction by Dr Hilary Marland, University of Warwick.Annotated and edited transcript of a Witness Seminar held on 6 June 2000. Introduction by Dr Hilary Marland, University of Warwick.Annotated and edited transcript of a Witness Seminar held on 6 June 2000. Introduction by Dr Hilary Marland, University of Warwick.In June 2000 a distinguished group of obstetricians, midwives, general practitioners, and medical statisticians came together to discuss maternal care. Chaired by Professor James Drife from Leeds, discussion ranged over many topics, including: the changing role of the obstetrician, general practitioners, and the increasing status and responsibility of midwives. Other subjects include the induction of labour, obstetric analgesia and anaesthesia, and debates about the place and kind of delivery that women wanted. Among those who attended and contributed were: Ms Beverley Beech, Dr Michael Bull, Sir Iain Chalmers, Professor Geoffrey Chamberlain, Ms Mary Cronk, Professor Peter Dunn, Ms Chloe Fisher, Mrs Caroline Flint, Ms Rosemary Jenkins, Dr Irvine Loudon, Professor Alison Macfarlane, Professor Lesley Page, Mr Roger Peel, Mr Elliot Philipp, Mrs Wendy Savage, Mrs Vicky Tinsley, Dame Margaret Wheeler and Professor Charles Whitfield. Christie D A, Tansey E M. (eds) (2001) Maternal care, Wellcome Witnesses to Twentieth Century Medicine, vol. 12. London: The Wellcome Trust Centre for the History of Medicine at UCL.The Wellcome Trust Centre for the History of Medicine at UCL is funded by the Wellcome Trust, which is a registered charity, no. 210183